Small Cap Biotech Stocks-Trades to Consider : Update-1 …Risk On!
Update-1...1/29/23 Risk On! Speculative small cap life science stocks continue to run with the XBI up 2.76% for the week. Movers for the week included: CRSP up 6.39%, CYRX up 6.07%, GERN up 4.7%, and VCYT up 4.58%. Some of the winners in our portfolio were losers in 2022 then sold and rebought....
J.P.Morgan Healthcare Conference #JPM23: Biotech Rally Favors Smaller caps
Biotech Stocks Rally During #JPM23 Favors Smaller Caps Bolt-On acquisitions expected to bolster product pipelines. Macro headwinds lessened with moderating inflation. Small and mid-cap biotechs provide an innovation narrative. Here are some takeaways from #JPM23: Large cap biopharmas that...
Nice gains During #JPM23 Week: Benign CPI Report Brings Hope for a “soft landing” …Updates-1
Update-1 1/13/23 Bank stocks beat with BAC and JPM trading higher. Bearish sentiment eroding as " risk-on " mentality takes hold before earnings. Continuing with #JPM Week Notes: 6. Continuing with the healthcare trend of more focused businesses and away from the conglomerate model GE...
Volatility Emerges After Brief Rally, Choppiness Continues…Update-1 Broad Rally
1/11/23...Update-1...Broad Rally favors large cap growth AAPL AMZN GOOGL MSFT but CPI data coming tomorrow. Healthcare stocks (XLV) lag after outperformance last year so a bit of rotation out of defensive to risk. Large cap biopharmas holding up nicely after #JPM 23 presentations: BIIB LLY...
Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired in Macro…Update-4…rally in spec biotechs!
Update-4...1/6/23...Broad rally sparked by latest economic data anticipating weaker economy and slowing wage growth . Bond yields are down. A '"soft landing '"scenario? We are at the JPMorgan Healthcare Conference next week. Closing trades: XLV at $135.67, IBB at $133.14, XBI at $83.16...